|
BE637389A
(https=)
|
1962-09-13 |
|
|
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
US4656187A
(en)
*
|
1981-08-03 |
1987-04-07 |
Eli Lilly And Company |
Treatment of mammary cancer
|
|
FI77839C
(fi)
|
1982-05-27 |
1989-05-10 |
Farmos Oy |
Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
|
|
GB2126576B
(en)
*
|
1982-06-25 |
1985-06-19 |
Farmos Group Limited |
Alkane and alkene derivatives
|
|
US5491173A
(en)
*
|
1982-06-25 |
1996-02-13 |
Orion-Yhtyma Oy |
Tri-phenyl alkene derivatives and their preparation and use
|
|
US4729999A
(en)
*
|
1984-10-12 |
1988-03-08 |
Bcm Technologies |
Antiestrogen therapy for symptoms of estrogen deficiency
|
|
DE3762617D1
(de)
*
|
1986-09-11 |
1990-06-13 |
Nat Res Dev |
Tamoxifenderivate.
|
|
US4977906A
(en)
*
|
1989-03-07 |
1990-12-18 |
Scipio William J Di |
Diurnal rehabilitation for incontinence trainer
|
|
US5189212A
(en)
*
|
1990-09-07 |
1993-02-23 |
University Of Georgia Research Foundation, Inc. |
Triarylethylene carboxylic acids with estrogenic activity
|
|
EP0551434B1
(en)
|
1990-10-01 |
1995-11-15 |
The Board Of Regents, The University Of Texas System |
High affinity tamoxifen derivatives and uses thereof
|
|
US6096874A
(en)
|
1990-10-01 |
2000-08-01 |
Board Of Regents, The University Of Texas System |
High affinity tamoxifen derivatives
|
|
US5219548A
(en)
*
|
1990-10-01 |
1993-06-15 |
Board Of Regents, The University Of Texas System |
High affinity halogenated-tamoxifen derivatives and uses thereof
|
|
US5118667A
(en)
*
|
1991-05-03 |
1992-06-02 |
Celtrix Pharmaceuticals, Inc. |
Bone growth factors and inhibitors of bone resorption for promoting bone formation
|
|
US5196435A
(en)
*
|
1991-11-21 |
1993-03-23 |
Eli Lilly And Company |
Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
|
|
GB9207437D0
(en)
|
1992-04-03 |
1992-05-20 |
Orion Yhtymae Oy |
Topical administration of toremifene and its metabolites
|
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
|
US5446203A
(en)
*
|
1992-08-25 |
1995-08-29 |
New York University |
Synthesis of haloenones and aryl or alkyl substituted enones or alkenes
|
|
GB2273704B
(en)
|
1992-12-16 |
1997-01-22 |
Orion Yhtymae Oy |
Triazolyl diaryl selective aromatase inhibiting compounds
|
|
DE4335876A1
(de)
*
|
1993-10-17 |
1995-04-20 |
Schering Ag |
Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
|
|
US5650425A
(en)
|
1994-04-04 |
1997-07-22 |
Pharmos Corporation |
Permanently ionic derivatives of steroid hormones and their antagonists
|
|
US5681835A
(en)
*
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
|
US5604248A
(en)
*
|
1994-05-05 |
1997-02-18 |
Eli Lilly And Company |
Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
|
|
US5470883A
(en)
*
|
1994-05-23 |
1995-11-28 |
Stromberg; Brent V. |
Method of treating peripheral vasoconstriction with tamoxifen citrate
|
|
US5441986A
(en)
*
|
1994-07-19 |
1995-08-15 |
Pfizer Inc. |
Estrogen agonists as remedies for prostate and cardiovascular diseases
|
|
GB9418067D0
(en)
|
1994-09-07 |
1994-10-26 |
Orion Yhtymae Oy |
Triphenylethylenes for the prevention and treatment of osteoporosis
|
|
US5658931A
(en)
*
|
1994-09-20 |
1997-08-19 |
Eli Lilly And Company |
Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds
|
|
DE4435368A1
(de)
|
1994-09-22 |
1996-03-28 |
Schering Ag |
Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
|
|
CN1167437A
(zh)
*
|
1994-11-29 |
1997-12-10 |
赫彻斯特马里恩鲁斯公司 |
用三芳基-乙烯衍生物治疗和预防骨质疏松的方法
|
|
US5552412A
(en)
*
|
1995-01-09 |
1996-09-03 |
Pfizer Inc |
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
|
|
US5821254A
(en)
*
|
1995-02-17 |
1998-10-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
|
|
GB9509572D0
(en)
|
1995-05-11 |
1995-07-05 |
Cancer Res Campaign Tech |
Cancer therapy
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
DE19526146A1
(de)
*
|
1995-07-07 |
1997-01-09 |
Schering Ag |
Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
HUP9903440A3
(en)
*
|
1996-01-29 |
2000-07-28 |
Lilly Co Eli |
Use of benzotiophene derivatives for preparing medicaments for increasing sphincter competence
|
|
GB9604577D0
(en)
*
|
1996-03-04 |
1996-05-01 |
Orion Yhtymae Oy |
Serum cholesterol lowering agent
|
|
WO1998011888A1
(en)
*
|
1996-09-19 |
1998-03-26 |
American Home Products Corporation |
Method of treating urinary incontinence
|
|
US5972921A
(en)
|
1997-12-12 |
1999-10-26 |
Hormos Medical Oy Ltd. |
Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
|
|
GB9803521D0
(en)
|
1998-02-19 |
1998-04-15 |
Orion Yhtymo Oy |
New compounds and pharmaceutical compositions thereof
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
AU4701299A
(en)
*
|
1998-06-23 |
2000-01-10 |
Stuart R. Adler |
Therapeutic applications of estrogenic carboxylic acids
|
|
EP1004306A3
(en)
*
|
1998-08-06 |
2000-06-07 |
Pfizer Products Inc. |
Estrogen agonists/antagonists
|
|
AU766648B2
(en)
*
|
1999-03-17 |
2003-10-23 |
Axys Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
TW593256B
(en)
*
|
1999-11-16 |
2004-06-21 |
Hormos Medical Oy Ltd |
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
|
|
GB0015246D0
(en)
*
|
2000-06-22 |
2000-08-16 |
Astrazeneca Ab |
Method for the treatment of urinary incontinence
|
|
WO2002003989A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
US6245819B1
(en)
*
|
2000-07-21 |
2001-06-12 |
Hormos Medical Oy, Ltd. |
Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
|
|
IL145838A
(en)
*
|
2000-10-16 |
2008-11-03 |
Pfizer Prod Inc |
Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
|
|
GB0030037D0
(en)
|
2000-12-08 |
2001-01-24 |
Karobio Ab |
Novel estrogen receptor ligands and methods III
|
|
FI111710B
(fi)
*
|
2001-05-04 |
2003-09-15 |
Hormos Medical Oy Ltd |
Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi
|
|
EP1441707A1
(en)
*
|
2001-11-09 |
2004-08-04 |
Pharmacia AB |
Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
|
|
RU2005101638A
(ru)
*
|
2002-06-25 |
2006-01-20 |
Уайт (Us) |
Использование циклокарбаматных производных для лечения гормонзависимых состояний
|
|
US20040248989A1
(en)
|
2003-06-05 |
2004-12-09 |
Risto Santti |
Method for the treatment or prevention of lower urinary tract symptoms
|
|
MX2008014825A
(es)
*
|
2006-05-22 |
2008-12-01 |
Hormos Medical Ltd |
Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana.
|